| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| TAX PREPARATION FEE (NON-ALLOC | 1,500 | 1,500 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 37045XBF2 GENERAL MOTORS | ||
| 58013MEN0 MCDONALDS CORP MTN | 254,196 | 275,945 |
| 911312BS4 UNITED PARCEL | ||
| 06367WGX5 BMO 24M EEM TW MTN | ||
| 548661DN4 LOWES COS INC | 251,709 | 274,033 |
| 912810RN0 U S TREASURY BD | ||
| 68389XBB0 ORACLE CORP | ||
| 94974BFC9 WELLS FARGO MTN | ||
| 912810SF6 U S TREASURY BD | ||
| 06367WMQ3 BANK OF MONTREAL MTN | ||
| 9128286M7 U S TREASURY NT | 465,010 | 462,746 |
| 9128285V8 U S TREASURY NT | 443,645 | 440,352 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 8AMCSDR86 SR REALTY TRUST, INC | 750,020 | 893,376 |
| 458140100 INTEL CORP | 76,272 | 92,700 |
| 931142103 WAL MART STORES INC | 200,868 | 289,380 |
| 848637104 SPLUNK INC | ||
| 893641100 TRANSDIGM GROUP INC | 61,784 | 136,164 |
| 031162100 AMGEN INC | 94,735 | 112,485 |
| 375558103 GILEAD SCIENCES INC | 46,697 | 44,873 |
| 00206R102 ATT INC | 69,978 | 49,200 |
| 38173M102 GOLUB CAPITAL BDC IN | 115,392 | 106,150 |
| 595112103 MICRON TECHNOLOGY IN | 91,070 | 148,574 |
| 440452100 HORMEL FOODS CORP | 49,969 | 72,825 |
| 902252105 TYLER TECHNOLOGIES I | 44,082 | 135,025 |
| 023135106 AMAZON.COM INC | 247,104 | 666,868 |
| 22160K105 COSTCO WHSL CORP | 42,571 | 150,441 |
| 91324P102 UNITED HEALTH GROUP | 218,551 | 401,712 |
| 594918104 MICROSOFT CORP | 231,069 | 672,640 |
| G1151C101 ACCENTURE PLC CL A | 88,630 | 248,730 |
| 110122157 BRISTOL MYERS SQUIBB | ||
| 501797104 L BRANDS INC | ||
| 83125X103 SLEEP NUMBER CORP | 571,529 | 1,204,995 |
| 91688F104 UPWORK INC | 118,888 | 102,173 |
| 57667L107 MATCH GROUP INC NEW | 68,421 | 134,366 |
| 29786A106 ETSY INC | 116,588 | 132,240 |
| 22266L106 COUPA SOFTWARE INC | 118,685 | 52,157 |
| 30063P105 EXACT SCIENCES CORPO | 123,659 | 68,179 |
| 74736L109 Q2 HOLDINGS INC | 119,237 | 73,403 |
| 25400W102 DIGITAL TURBINE INC | 116,536 | 121,797 |
| 45168D104 IDEXX CORP COM | 117,837 | 156,713 |
| 98954M101 ZILLOW GROUP INC | 117,815 | 50,585 |
| 30303M102 FACEBOOK INC A | 57,858 | 100,905 |
| 76680R206 RINGCENTRAL INC | 70,209 | 56,205 |
| 037833100 APPLE INC | 110,696 | 266,355 |
| 70432V102 PAYCOM SOFTWARE INC | 119,300 | 105,873 |
| 34959E109 FORTINET INC | 68,246 | 161,730 |
| 92337F107 VERACYTE INC | 1,262 | 1,112 |
| 632307104 NATERA INC | 4,213 | 3,269 |
| 77313F106 ROCKET PHARMACEUTICA | 1,058 | 677 |
| N71542109 PROQR THERAPEUTICS N | 809 | 777 |
| 69404D108 PACIFIC BIOSCIENCES | 2,050 | 1,514 |
| 14167L103 CAREDX INC | 1,401 | 955 |
| 09061G101 BIOMARIN PHARMACEUTI | 3,792 | 4,329 |
| 359664109 FULGENT GENETICS INC | 608 | 704 |
| 09609G100 BLUEBIRD BIO INC | 225 | 280 |
| 45773H201 INOVIO PHARMACEUTICA | 624 | 409 |
| 92532F100 VERTEX PHARMACEUTICA | 3,590 | 4,172 |
| H17182108 CRISPR THERAPEUTICS | 3,167 | 2,046 |
| 438083107 HOMOLOGY MEDICINES I | 622 | 288 |
| 803607100 SAREPTA THERAPEUTICS | 2,688 | 2,882 |
| N72482123 QIAGEN N V | 3,911 | 4,057 |
| 800677106 SANGAMO BIOSCIENCES | 460 | 375 |
| 63009R109 NANOSTRING TECHNOLOG | 1,004 | 760 |
| 12233L107 BURNING ROCK BIOTECH | 888 | 438 |
| 09627Y109 BLUEPRINT MEDICINES | 2,488 | 2,571 |
| 74019P108 PRECISION BIOSCIENCE | 608 | 363 |
| 45826J105 INTELLIA THERAPEUTIC | 3,915 | 3,074 |
| N90064101 UNIQURE B.V. | 584 | 332 |
| Y95308105 WAVE LIFE SCIENCES P | 461 | 261 |
| 69366J200 PTC THERAPEUTICS INC | 1,219 | 1,195 |
| 28106W103 EDITAS MEDICINE INC | 1,637 | 717 |
| 501147102 KRYSTAL BIOTECH INC | 449 | 560 |
| 40131M109 GUARDANT HEALTH INC | 4,438 | 3,501 |
| 35104E100 4D MOLECULAR THERAPE | 613 | 395 |
| 88339J105 TRADE DESK INC THE C | 129,284 | 137,460 |
| 14843C105 CASTLE BIOSCIENCES I | 675 | 386 |
| 67577C105 OCUGEN INC | 606 | 364 |
| 90400D108 ULTRAGENYX PHARMACEU | 2,620 | 2,270 |
| 05370A108 AVIDITY BIOSCIENCES | 552 | 570 |
| 29414B104 EPAM SYSTEMS INC | 118,224 | 200,535 |
| N2451R105 CUREVAC N V | 1,245 | 755 |
| 04280A100 ARROWHEAD PHARMACEUT | 2,536 | 2,652 |
| 07373V105 BEAM THERAPEUTICS IN | 1,943 | 1,514 |
| 60770K107 MODERNA INC | 4,770 | 2,794 |
| 83587F202 SORRENTO THERAPEUTIC | 916 | 535 |
| 070830104 BATH BODY WORKS INC | 396,524 | 1,319,031 |
| 901384107 2SEVENTY BIO INC | 264 | 231 |
| 15117K103 CELLECTIS A D R | 503 | 292 |
| 98983V106 ZUORA INC CLASS A | 107,839 | 121,943 |
| 71535D106 PERSONALIS INC | 495 | 328 |
| 452327109 ILLUMINA INC COM | 3,150 | 2,663 |
| 45784P101 INSULET CORPORATION | 114,710 | 106,428 |
| 70975L107 PENUMBRA INC | 136,791 | 143,660 |
| 75901B107 REGENXBIO INC | 725 | 523 |
| 88025U109 10X GENOMICS INC CLA | 3,131 | 2,979 |
| 03969T109 ARCTURUS THERAPEUTIC | 783 | 555 |
| 68386H103 OPPFI INC | 51,105 | 22,700 |
| 90138Q108 23ANDME HOLDING CO C | 1,448 | 1,192 |
| 62855J104 MYRIAD GENETICS INC | 1,083 | 911 |
| 01626L105 ALIGOS THERAPEUTICS | 556 | 404 |
| 90184D100 TWIST BIOSCIENCE COR | 1,921 | 1,316 |
| 926400102 VICTORIAS SECRET AND | 93,126 | 349,902 |
| 02043Q107 ALNYLAM PHARMACEUTIC | 3,940 | 3,561 |
| 68570P101 ORCHARD THERAPEUTICS | 503 | 224 |
| 46185L103 INVITAE CORP | 2,433 | 1,252 |
| G59665102 MEIRAGTX HOLDINGS PL | 437 | 807 |
| 462222100 IONIS PHARMACEUTICAL | 2,171 | 1,795 |
| 019770106 ALLOGENE THERAPEUTIC | 726 | 433 |
| 98973P101 ZIOPHARM ONCOLOGY IN | 375 | 240 |
| 09075V102 BIONTECH SE A D R | 4,620 | 3,351 |
| 87918A105 TELADOC INC | 113,639 | 36,728 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| 97MSCZ9H5 RADUX DEVICES LLC | AT COST | 183,465 | 183,465 |
| 97MSCW6Z5 SUMMIT PARTNERS SUB | AT COST | 469,173 | 270,406 |
| 464287432 ISHARES 20 YEAR TREA | AT COST | 368,937 | 326,018 |
| 464287242 ISHARES IBOXX INVEST | AT COST | 356,917 | 359,659 |
| 96MSCCGT4 CB OFFSHORE CREDIT O | AT COST | 491,496 | 258,260 |
| CALL AND PUT OPTIONS | |||
| 96MSCT5H5 ALPHACOPIA PARTNERS | AT COST | 500,000 | 500,000 |
| 96MSCMPW5 REDMILE BIOPHARMA IN | AT COST | 78,746 | 78,746 |
| 96MSCHH13 BANNEKER PARTNERS FU | AT COST | 396,663 | 540,824 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ACCRUED INCOME | 0 | 0 | |
| 000000000 MISCELLANEOUS ENTRY | 23 | 6 | 6 |
| Description | Amount |
|---|---|
| POAI | 3,419 |
| PARTNERSHIP INCOME ADJUSTMENT | 134,608 |
| L BRANDS ADJ | 93,618 |
| BLUEBIRD BIO INC ADJ | 273 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CB OFFSHORE CREDIT OPP | 3,365 | 3,365 | 0 | |
| BANNEKER PARTNERS FUND | 19,031 | 18,110 | 0 | |
| SUMMIT PARTNERS SUBORDINATED D | 2,576 | 2,576 | 0 | |
| REDMILE BIOPHARMA INVESTMENTS | 481 | 481 | 0 | |
| OTHER MISC EXPENES | 3,283 | 0 | 3,283 | |
| STATE FILING FEE/TAX | 25 | 0 | 25 | |
| RADUX LP | 17 | 17 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| CB OFFSHORE | 31,504 | 31,504 | |
| SUMMIT PARTNERS | 66,036 | 66,036 | |
| REDMILE BIOPHARMA | -183 | -183 | |
| BANNKER PARTNERS FUND I | 81,440 | 50,615 | |
| RADUX DEVICES LLC | -23,707 | -23,707 |
| Description | Amount |
|---|---|
| PARTNERSHIP DISTRIBUTION ADJUSTMENT | 593,603 |
| RADUX LP BASIS ADJUSTMENT | 51,490 |
| COST BASIS ADJUSTMENT | 109,769 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OTHER EXPENSE (NON-DEDUCTIBLE | 54,645 | 49,180 | 5,464 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 278 | 278 | 0 | |
| FEDERAL ESTIMATES - PRINCIPAL | 2,758 | 0 | 0 |